When it comes to science, discovery never ends. At Benchtalk Series, you’ll level up your skills through peer-to-peer discussions and get a sneak peek into the biggest solutions designed to accelerate and innovate science.
.png)
Benchtalk Series is the ideal place for content sharing, connection, and local scientific community building. At these free events, like-minded scientific professionals come together to accelerate the speed and impact of biotech R&D and walk away with new ideas and insights to get the most out of their work.
We know it’s rare to get out of the lab and be face to face with your peers. Join us to connect with your colleagues—in real life—and have conversations that inspire new thinking to take back to the bench.
When it comes to science, discovery never ends. At Benchtalk Series, you’ll level up your skills through peer-to-peer discussions and get a sneak peek into the biggest solutions designed to accelerate and innovate science.
Your work is hard and celebrating breakthroughs doesn't often happen easily. Come to Benchtalk Series to relax, unwind, and have some fun. We promise good food and ample networking.
Check-in, have coffee, and get to know other guests before the event starts.
Jamie Kincaid, Leader, Professional Services EMEA, Benchling
Hear from Benchling about the state of biotech and the newest innovations coming to support R&D.
Matt Todd, Head of Architecture, Ori Biotech
Cell and gene therapies (CGT) have proven effective, yet only a very small portion of patients are able to access treatments, typically as third- or fourth-line treatments. Ori Biotech are leading manufacturing technology company building a CGT manufacturing platform to enable widespread access to these life-changing treatments.
However, this requires urgent modernization of the legacy and manual technologies used during therapy development and manufacturing. These outdated technologies are having a dramatically negative effect on scalability, resulting in extremely limited manufacturing slots and very high cost of goods-resulting in patients dying whilst on waitlists for CGT.
Join this session to understand how other industries have solved these challenges through digital transformation and automation, and how their learnings can be applied to CGT to enable the industrialisation of patient-specific therapies. You will also gain insights into how Ori Biotech is tackling digitalisation in the CGT space.
Estefani Lencer, Research Laboratory Manager, MOA Technology
Eliot Randle, Managing partner & co-founder, Digital Lab Consulting
Life sciences organizations face a growing challenge in extracting value and insights from the increasingly large volumes of diverse data that they generate. High quality, unambiguous data is at the heart of any digital transformation or lab of the future initiative.
In this session we’ll explain the pivotal role that the FAIR principles (ensuring data is Findable, Accessible, Interoperable and Reusable) have in ensuring that data can be exchanged and exploited more effectively. We’ll also describe some of the strategies that can be used to support your FAIR data journey.
In need of more hands-on support, or a solution that connects multiple labs? Check out our paid subscriptions.
Start free trial
